Jan 10, 2022 / 03:30PM GMT
Tessa Thomas Romero - JPMorgan Chase & Co, Research Division - Associate
Welcome, everyone, to the 40th Annual JPMorgan Healthcare Conference. My name is Tess Romero, I'm one of the senior analysts here at JPMorgan. I'm joined by [Taylor Hanley] from my team.
Our next presenting company is Passage Bio, and presenting on behalf of the company, we have CFO, Simona King. Before I hand it over to Simona, I just wanted to remind all of our listeners to please use the Ask A Question feature in the portal to ask a question, and I'm happy to ask it on your behalf. And over to you, Simona.
Simona King - Passage Bio, Inc. - CFO
Great. Thanks, Tessa, and hello, everyone. I'm Simona King, CFO at Passage Bio. I will be giving the presentation this morning, while Bruce Goldsmith is recovering quickly, he has cold-like symptoms and a cough that he felt might interrupt the presentation delivery. He will be joining the Q&A as well as meetings throughout the week.
Passage Bio's vision is to transform the lives of patients with devastating CNS diseases.
Passage Bio Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
